Search

Ardelyx Inc

Chiusa

SettoreSettore sanitario

3.38 -0.29

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

3.33

Massimo

3.49

Metriche Chiave

By Trading Economics

Entrata

21M

-17M

Vendite

26M

121M

EPS

-0.07

Margine di Profitto

-13.833

Dipendenti

489

EBITDA

20M

-10M

Raccomandazioni

By TipRanks

Raccomandazioni

Fortemente da comprare

Previsioni per 12 mesi

+301.92% upside

Dividendi

By Acuity

Utili prossimi

29 ott 2026

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

-321M

909M

Apertura precedente

3.67

Chiusura precedente

3.38

Notizie sul Sentiment di mercato

By Acuity

73%

27%

300 / 339 Classifica in Healthcare

Ardelyx Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

16 set 2026, 20:10 UTC

Ardelyx Inc is seeing modest gains, increasing slightly since Tuesday's close, though it remains below its 20-day moving average after four consecutive declines.

15 set 2026, 20:07 UTC

Ardelyx Inc. shares are lower, extending a four-session decline amid negative sentiment from the NY Empire State Manufacturing Index's sharp drop.

14 set 2026, 20:13 UTC

Ardelyx Inc shares are higher in after-market trading, despite recent declines and no specific news driving the move. The U.S. dollar is strengthening.

10 set 2026, 20:01 UTC

Ardelyx Inc shares are lower during Thursday's session, breaking a trend of higher daily closes. No specific news was identified for the decline.

9 set 2026, 20:07 UTC

Ardelyx Inc shares are higher today, continuing an upward trend despite earlier pulling back from session highs. No specific news was identified for the movement.

8 set 2026, 20:01 UTC

Ardelyx Inc. shares are lower as biotechnology stocks face downward pressure. The asset pulled back after an early high during Tuesday's session.

2 set 2026, 20:08 UTC

Ardelyx Inc is rising on biotechnology sector strength during Wednesday's session, despite being below its 20-day moving average and near the one-month range low.

1 set 2026, 23:06 UTC

Ardelyx Inc shares are lower in after-market hours, continuing a decline since Tuesday's close. The stock remains below its 20-day moving average.

31 ago 2026, 20:07 UTC

Ardelyx Inc shares are lower amid broader market pressure from comments at the Jackson Hole Economic Symposium about persistent inflation and potential rate hikes.

28 ago 2026, 20:08 UTC

Ardelyx Inc. shares are trading roughly flat amid no specific news. The stock remains near the lower end of its one-month trading range.

26 ago 2026, 19:16 UTC

Ardelyx Inc. shares are higher Wednesday, recovering from an earlier dip amid notable volatility and broader market dynamics reflecting persistent inflationary pressures.

25 ago 2026, 20:07 UTC

Ardelyx Inc shares are gaining amid broader market trends, supported by easing Treasury yields. The stock remains below its 20-day moving average.

21 ago 2026, 19:16 UTC

Ardelyx Inc shares are higher today, continuing positive momentum since Thursday. No specific news was identified to explain the price movement.

20 ago 2026, 20:01 UTC

News

Ardelyx Inc shares are lower amid a securities investigation into its revised IBSRELA revenue guidance, which was cut to $350-$370 million.

19 ago 2026, 23:01 UTC

Ardelyx Inc. shares are higher in after-market trading, reflecting broader market gains. The stock remains below its 20-day moving average.

18 ago 2026, 23:06 UTC

Ardelyx Inc. shares are roughly flat in after-market trading. The stock is down significantly compared to its month-ago close and below its 20-day moving average.

17 ago 2026, 19:26 UTC

News

Ardelyx shares are lower as Levi & Korsinsky investigates potential federal securities law violations amid reduced revenue guidance for IBSRELA.

14 ago 2026, 23:56 UTC

Ardelyx Inc. shares declined in after-market trading, continuing a broader trend of significant decline over the past month, remaining below the 20-day moving average.

13 ago 2026, 23:01 UTC

Ardelyx Inc. shares advanced modestly in after-market trading, though they remain significantly below the 20-day moving average and near the one-month range's lower end.

12 ago 2026, 23:26 UTC

Ardelyx Inc. shares were trading roughly flat in after-market hours. The stock has declined significantly over the past month amid broader market weakness.

11 ago 2026, 19:56 UTC

Ardelyx Inc's shares are lower today, reflecting a broader decline in the biotechnology sector. Investors monitor macroeconomic factors ahead of the Consumer Price Index report.

10 ago 2026, 23:56 UTC

Ardelyx Inc shares are higher in after-market trading, despite no specific news driving the move. Recent market conditions include cautious optimism following a jobs report.

7 ago 2026, 23:31 UTC

News

Ardelyx shares are higher in after-market trading as TD Cowen maintains a Buy rating and lowers the price target to $10.

6 ago 2026, 23:31 UTC

News
Social Media

Ardelyx Inc. reports Q2 revenue of $118.1 million, missing expectations. Shares decline in after-market trading following revised financial guidance and a net loss of $16.7 million.

3 ago 2026, 19:16 UTC

Ardelyx Inc. shares are trading roughly flat with no specific news identified. The stock remains below its 20-day moving average.

31 lug 2026, 19:16 UTC

Ardelyx Inc. shares are lower, reflecting broader market trends amid rising yields and inflationary pressures, particularly after a notable increase in crude oil prices.

30 lug 2026, 23:51 UTC

Ardelyx Inc. shares are lower in after-market trading, remaining below their 20-day moving average amid broader market weakness.

22 lug 2026, 19:31 UTC

Ardelyx Inc shares are higher in Wednesday's session, continuing a modest rise since Tuesday's close. The stock remains below its 20-day moving average.

20 lug 2026, 19:02 UTC

Ardelyx shares are lower today, reflecting broader weakness in the biotechnology sector. The stock has declined since Friday's close with no specific news identified.

Confronto tra pari

Modifica del prezzo

Ardelyx Inc Previsione

Obiettivo di Prezzo

By TipRanks

301.92% in crescita

Previsioni per 12 mesi

Media 13.625 USD  301.92%

Alto 18 USD

Basso 9 USD

Basato su 8 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Ardelyx Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Fortemente da comprare

8 ratings

8

Acquista

0

Mantieni

0

Vendi

Sentiment

By Acuity

300 / 339 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Prove ribassiste

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sotto la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Ardelyx Inc

Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor for the treatment of patients with irritable bowel syndrome with constipation. It also develops XPHOZAH, which is in Phase III clinical trial to reduce serum phosphorus in adults with chronic kidney disease (CKD)on dialysis, or hyperphosphatemia; RDX013, a potassium secretagogue, for the treatment of elevated serum potassium, or hyperkalemia, a problem among patients with kidney and/or heart failure; and RDX020, for adult patients with metabolic acidosis, a serious electrolyte disorder. The company has agreements with Kyowa Kirin, Fosun Pharmaceutical Industrial Development Co. Ltd., and Knight Therapeutics, Inc. for the development and commercialization of tenapanor in their respective territories. The company was formerly known as Nteryx, Inc. and changed its name to Ardelyx, Inc. in June 2008. Ardelyx, Inc. was incorporated in 2007 and is headquartered in Waltham, Massachusetts.
help-icon Live chat